Potential crosstalk between the renin-angiotensin system and Neuropilin-1 pathways in experimental rheumatoid arthritis
European Journal of Pharmaceutical Sciences · 2026
DOI: 10.1016/j.ejps.2026.107465 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutical Sciences, 2026. Verfasst von Nourhan E Shahin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Health Affairs Directorate in Alexandria, Egypt. Hauptthemen laut MEDLINE: Renin-Angiotensin System, Neuropilin-1, Arthritis, Rheumatoid, Arthritis, Experimental. Die Arbeit nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a systemic autoimmune disorder characterized by persistent synovial inflammation, pathological angiogenesis, and progressive joint destruction. Emerging evidence implicates the renin-angiotensin system (RAS) and neuropilin-1 (NRP-1) as key modulators of RA pathogenesis through regulation of inflammatory signaling, vascular remodeling, and osteoclastogenesis. This study explored the mechanistic interplay between RAS and NRP-1 signaling in a rat model of RA induced by complete Freund's adjuvant. Experimental groups received valsartan (VAL), an angiotensin II type-1 receptor (AT-1R) antagonist; ramipril (RAM), an ACE inhibitor or methotrexate (MTX), the standard anti-rheumatic agent. NRP-1 ligand-binding (VEGF-165/Sema3A) and dimerization-associated domain expression were evaluated via immunohistochemistry and western blot. Transcriptional expression of VEGF-165, Sema3A was quantified using qRT-PCR, while RhoA, p-ERK protein levels were assessed by ELISA. Systemic inflammatory mediators (anti-CCP, TNF-α, IL-1β) and the bone resorption marker RANKL were also determined. Histopathological and scanning electron microscopy (SEM) analyses with morphometric evaluation assessed joint integrity. Both VAL and RAM significantly modulated NRP-1 signaling, influencing ligand-receptor interactions, dimerization, and downstream mediators (RhoA, p-ERK). These effects were accompanied by reduced inflammatory activity and preservation of bone and cartilage structure, suggesting that RAS blockade may confer chondroprotective and anti-inflammatory benefits via modulation of the NRP-1 axis. Collectively, the findings highlight a potential mechanistic cross-talk between RAS and NRP-1 pathways, offering a promising direction for future studies aimed at developing novel adjunctive strategies for RA management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health Affairs Directorate in Alexandria, Egypt.
- Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Pharos University in Alexandria, Egypt. Electronic address: nesrine.saeed@pua.edu.eg.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Egypt.
Zitieren
APA
Shahin, N. E., El-Mezayen, N. S., & Khattab, M. M. (2026). Potential crosstalk between the renin-angiotensin system and Neuropilin-1 pathways in experimental rheumatoid arthritis. European Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.ejps.2026.107465
Vancouver
Shahin NE, El-Mezayen NS, Khattab MM. Potential crosstalk between the renin-angiotensin system and Neuropilin-1 pathways in experimental rheumatoid arthritis. European Journal of Pharmaceutical Sciences. 2026. doi:10.1016/j.ejps.2026.107465
BibTeX
@article{Shahin2026,
author = {Shahin, Nourhan E and El-Mezayen, Nesrine S and Khattab, Mahmoud M},
title = {Potential crosstalk between the renin-angiotensin system and Neuropilin-1 pathways in experimental rheumatoid arthritis},
journal = {European Journal of Pharmaceutical Sciences},
year = {2026},
doi = {10.1016/j.ejps.2026.107465}
}
EUVIMED